In contrast to the fact that all of the 10 patients with clinical diagnosis of TSC-LAM were found to carry TSC1/2 mutations, only 36 of the 51 (70.6%) patients with clinical diagnosis of S-LAM were found to carry TSC1/2 mutations (P<0. Here, TSC1 is linked to lymphangioleiomyomatosis.